Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Aarti Drugs Ltd Updates On Occurrence Of Accident At Tarapur Plant


Tuesday, 2 Apr 2013 04:03am EDT 

Aarti Drugs Ltd announced that the Company is having nine manufacturing units in Tarapur, Maharashtra & Sarigam, Gujarat, There was an explosion in one of the plants in manufacturing unit located at Plot No. N - 198 Tarapur on March 22, 2013. This plant was manufacturing MNI, an intermediate which was further processed to manufacture two APIs. These two APIs contribute about 13% of the total turnover of the Company on an annualised basis. Meanwhile the Company has taken efforts to procure the affected intermediate from outside and the supplies would be restored within a month approximately. Timeframe to rebuild the affected intermediate plant is being worked out. Assets of the affected plant are adequately insured. 

Company Quote

745.6
-17.25 -2.26%
22 Aug 2014